The Medicare Payment Advisory Commission yesterday and today discussed a number of issues, including ways indirect medical education payments could be reallocated so that IME adjustments would apply to both inpatient and outpatient care. The commission considered the impact modifications to the IME program would have on hospitals’ Medicare payments and the potential for a performance-based component within the program. Among other issues, the commission examined MedPAC’s evaluation of Medicare’s Hospital Readmissions Reduction Program; a value incentive program for post-acute care providers; and the effects of Medicare Advantage “spillover” on Medicare fee-for-service spending and coding.

Related News Articles

Headline
House Democratic leaders today released the Lower Drug Costs Now Act, a bill that would make a series of changes to the Medicare program in an effort to lower…
Headline
According to a committee summary, the draft bill would provide $93.4 billion in discretionary funding for the Department of Health and Human Services, an…
Headline
The Centers for Medicare…
Headline
Rebates reduced the growth in Medicare Part D spending for brand-name drugs between 2011 and 2015, but spending for brand-name drugs with rebates still grew by…
Headline
The Centers for Medicare…
Perspective
Two weeks ago, I wrote about the